Interstitial lung disease (ILD) is a common complication of systemic autoimmune rheumatic diseases 1-5 and a cause of significant morbidity and mortality in affected patients. 1,6-8 Progression of ...

Lung involvement is common in CTD with prevalence estimates of up to 80%, [17] with diffuse interstitial lung disease (ILD) being the most common pulmonary manifestation.

Interstitial lung disease (ILD), also known as diffuse parenchymal lung disease (DPLD), refers to a group of lung diseases affecting the interstitium (the tissue and space around the air sacs of ...

This lung disease can lead to reduced lung capacity and breathing difficulties. Interstitial Lung Disease symptoms often include a chronic dry cough, shortness of breath, and fatigue, which may ...

Source Reference: McDermott GC, Sparks JA "Tumour necrosis factor inhibitor safety in rheumatoid arthritis-associated interstitial lung disease" Lancet Rheumatol 2025; DOI: 10.1016/S2665-9913 (24 ...

Sampling adequacy: Across the analyzed studies, bronchoscopy-guided parenchymal biopsies yielded molecular-testing specimens equivalent in quality and quantity to those obtained via percutaneous ...

This new lung disease AI model gives us a clue as to what is yet to come, with it able to correctly identify nuances that differentiate, for example COVID-19 from pneumonia.

Dr. Bryant Lin, a professor at Stanford University School of Medicine, has been diagnosed with stage 4 lung cancer despite never smoking Lin has dedicated a lot of his career to researching the ...